322 results on '"Kaveri, Srinivas V."'
Search Results
2. Prevalence and Gene Characteristics of Antibodies with Cofactor-induced HIV-1 Specificity
3. Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma
4. A Cryptic Polyreactive Antibody Recognizes Distinct Clades of HIV-1 Glycoprotein 120 by an Identical Binding Mechanism
5. Thermodynamic stability contributes to immunoglobulin specificity
6. Methods for Posttranslational Induction of Polyreactivity of Antibodies
7. Mechanisms of Action of Intravenous Immunoglobulin (IVIg) in Immune-Mediated Diseases
8. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
9. Heme Interacts with C1q and Inhibits the Classical Complement Pathway
10. Proteolytic antibodies activate factor IX in patients with acquired hemophilia
11. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination
12. A Role for Exposed Mannosylations in Presentation of Human Therapeutic Self-Proteins to CD4+ T Lymphocytes
13. Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
14. Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibody
15. Invariance and Restriction Toward a Limited Set of Self-Antigens Characterize Neonatal IgM Antibody Repertoires and Prevail in Autoreactive Repertoires of Healthy Adults
16. Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A
17. Functional variability of antibodies upon oxidative processes
18. Insight into the mechanism of the acquired antibody auto-reactivity
19. The role of VWF in the immunogenicity of FVIII
20. T Cell–Derived IL-22 Amplifies IL-1β–Driven Inflammation in Human Adipose Tissue: Relevance to Obesity and Type 2 Diabetes
21. A Cellular Viewpoint of Anti-FVIII Immune Response in Hemophilia A
22. Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond
23. Antibodies Use Heme as a Cofactor to Extend Their Pathogen Elimination Activity and to Acquire New Effector Functions
24. Immune response against therapeutic factor VIII in hemophilia A patients—A survey of probable risk factors
25. Transition towards antigen-binding promiscuity of a monospecific antibody
26. Gain of function of immunoglobulins after partial unfolding or cofactor binding
27. Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity
28. Ferrous Ions and Reactive Oxygen Species Increase Antigen-binding and Anti-inflammatory Activities of Immunoglobulin G
29. Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells
30. Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?
31. Stability of Natural Self-Reactive Antibody Repertoires During Aging
32. Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance
33. Removal of Mannose-Ending Glycan at Asn2118 Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic Cells
34. AUTOANTIBODIES IN THERAPEUTIC PREPARATIONS OF HUMAN INTRAVENOUS IMMUNOGLOBULIN (IVIG)
35. LIST OF CONTRIBUTORS
36. Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice
37. Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis
38. Catalytic activity of antibodies against factor VIII in patients with hemophilia A
39. Immunotherapy of viral infections
40. Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A
41. Human mannose receptor (CD206) in immune response: novel insights into vaccination strategies using a humanized mouse model
42. Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A
43. Natural Antibodies to Factor VIII
44. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
45. Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
46. Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A
47. Removal of Mannose-Ending Glycan at Asn2118 Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic Cells.
48. Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A
49. Complement C3 is a novel modulator of the anti-factor VIII immune response
50. The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.